These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32100786)

  • 1. Novel β-1,3-d-glucan porous microcapsule enveloped folate-functionalized liposomes as a Trojan horse for facilitated oral tumor-targeted co-delivery of chemotherapeutic drugs and quantum dots.
    Li X; Zhao Z; Yang Y; Liu Z; Wang J; Xu Y; Zhang Y
    J Mater Chem B; 2020 Mar; 8(11):2307-2320. PubMed ID: 32100786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
    Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
    J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection-prevention on Ti implants by controlled drug release from folic acid/ZnO quantum dots sealed titania nanotubes.
    Xiang Y; Liu X; Mao C; Liu X; Cui Z; Yang X; Yeung KWK; Zheng Y; Wu S
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():214-224. PubMed ID: 29407150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects.
    Ye DX; Ma YY; Zhao W; Cao HM; Kong JL; Xiong HM; Möhwald H
    ACS Nano; 2016 Apr; 10(4):4294-300. PubMed ID: 27018822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
    Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
    Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-mediated green synthesis and folic-acid modification of CuS quantum dots for photoacoustic imaging guided photothermal therapy of tumor.
    Yu W; Yu N; Wang Z; Li X; Song C; Jiang R; Geng P; Li M; Yin S; Chen Z
    J Colloid Interface Sci; 2019 Nov; 555():480-488. PubMed ID: 31401480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.
    Godugu C; Doddapaneni R; Patel AR; Singh R; Mercer R; Singh M
    Pharm Res; 2016 Jan; 33(1):137-54. PubMed ID: 26286185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.
    Wang W; Wang Y; Wang Y; Gong H; Zhu H; Liu M
    IET Nanobiotechnol; 2019 Aug; 13(6):640-649. PubMed ID: 31432799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc oxide end-capped Fe
    Liu M; Sun X; Liao Z; Li Y; Qi X; Qian Y; Fenniri H; Zhao P; Shen J
    Drug Deliv; 2019 Dec; 26(1):732-743. PubMed ID: 31340678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
    Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
    Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
    Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
    Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: synthesis, characterization and in vitro drug delivery response.
    Yuan Q; Hein S; Misra RD
    Acta Biomater; 2010 Jul; 6(7):2732-9. PubMed ID: 20100604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell nanocarriers with ZnO quantum dots-conjugated Au nanoparticle for tumor-targeted drug delivery.
    Chen T; Zhao T; Wei D; Wei Y; Li Y; Zhang H
    Carbohydr Polym; 2013 Feb; 92(2):1124-32. PubMed ID: 23399137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
    Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
    J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid functionalized ZnO quantum dots for targeted cancer cell imaging.
    Ma YY; Ding H; Xiong HM
    Nanotechnology; 2015 Jul; 26(30):305702. PubMed ID: 26148516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery.
    Cai X; Luo Y; Zhang W; Du D; Lin Y
    ACS Appl Mater Interfaces; 2016 Aug; 8(34):22442-50. PubMed ID: 27463610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
    Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
    Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.